- CConnexion
RééDOC
75 Boulevard Lobau 54042 NANCY cedex Christelle Grandidier Documentaliste 03 83 52 67 64 0
|
Gentamicin treatment of Duchenne and Becker muscular dystrophy due to nonsense mutations
WAGNER KR; HAMED S; HADLEY DW
ANN NEUROL , 2001, vol. 49, n° 6, p. 706-711 Doc n°: 101284 Localisation : Bibliothèque Universitaire de Médecine de Nancy Descripteurs : AB311 - MYOPATHIE DE DUCHENNE DE BOULOGNE Aminoglycosides have previously been shown to suppress nonsense mutations, allowing translation of full-length proteins in vitro and in animal models. In the mdx mouse, where muscular dystrophy is due to a nonsense mutation in the dystrophin gene, gentamicin suppressed truncation of the protein and ameliorated the phenotype. A subset of patients with Duchenne and Becker muscular dystrophy similarly possess a nonsense mutation, causing premature termination of dystrophin translation. Four such patients, with various stop codon sequences, were treated once daily with intravenous gentamicin at 7.5 mg/kg/day for 2 weeks. No ototoxicity or nephrotoxicity was detected. Full-length dystrophin was not detected in pre- and post-treatment muscle biopsies. Langue : ANGLAIS Identifiant basis : 2001217233 |
0
|